The groundbreaking success of Viagra undeniably transformed the medication landscape, but investing in companies heavily reliant on off-patent versions presents a complex picture. Although early returns were impressive, the cessation of patents and the appearance of less expensive alternatives have weakened the customer base. Thus, a thorough evalu